Peter Honig, M.D., M.P.H, is Senior Vice President and Head of Worldwide Safety and Regulatory (WSR). This organization is responsible for ensuring regulatory compliance throughout a product's life cycle, and most importantly, developing and implementing strategies to deliver and advance Pfizer's commitment to patient safety.
“Our work begins and ends with our commitment to patient safety across all levels within Pfizer. For WSR, we're committed to closely examining all clinical programs at the global, regional and specific country levels, and continue to diligently monitor and review a product through a systematic approach once it’s reached the market.”
Senior Vice President, Worldwide Safety and Regulatory
Peter Honig, M.D., M.P.H, is Senior Vice President and Head of Worldwide Safety and Regulatory (WSR) at Pfizer. In this role, Dr. Honig leads Pfizer's commitment to patient safety by working across the organization to ensure regulatory efficiency, quality control and compliance throughout all stages of product development and once marketed.
Prior to joining Pfizer, Dr. Honig was the Head of Global Regulatory Affairs, Patient Safety and Quality Assurance at AstraZeneca. Preceding his role with AstraZeneca, Dr. Honig served as Senior Vice President, Worldwide Regulatory Affairs and Product Safety at Merck Research Laboratories and also held senior leadership positions with the U.S. Food and Drug Administration (FDA).
Dr. Honig has been the PhRMA representative to the International Conference on Harmonization (ICH) Steering Committee since 2002 and is the current co-chair of the ICH Global Cooperation Group and regions. He is the industry representative to the FDA Advisory Committee on Pharmaceutical Science and is the Associate Editor of Clinical Pharmacology and Therapeutics. Dr. Honig has a faculty appointment at the Uniformed Services University of the Health Sciences and is a past President of the American Society for Clinical Pharmacology and Therapeutics (ASCPT).
Dr. Honig earned his baccalaureate, medical and public health degrees from Columbia University in New York. He completed postgraduate training at Northwestern Memorial Hospital, Northwestern University Medical School and is board-certified in internal medicine and clinical pharmacology. In addition, Dr. Honig has authored numerous peer viewed publications and book chapters.